Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Cybin Inc CYBN


Primary Symbol: N.CYBN

Cybin Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company creates psychedelic-based therapeutics to address the unmet need for treatment options for people who suffer from mental health conditions. Its N,N-dimethyltryptamine (DMT) and dDMT programs creates a dataset of systematic research on these psychedelic molecules. The Company is developing CYB003, a proprietary... see more

Bullboard (NEO:CYBN)

View:
Post by thorgb1on Jun 21, 2021 8:37am

News: presenting at investment conference….

News here: https://stockhouse.com/news/press-releases/2021/06/21/ceo-presenting-on-the-first-emerging-growth-investors-hub-joint-conference-on
Post by thorgb1on Jun 17, 2021 8:09am

News: some scientific stuff about a molecule….

News here: https://www.businesswire.com/news/home/20210616005144/en/
Post by thorgb1on Jun 08, 2021 9:39am

News: Sponsors new Covid burnout study…..

News here: https://www.businesswire.com/news/home/20210608005236/en/
Post by thorgb1on Jun 01, 2021 11:13am

News: Sponsors new study on brain effects....

News here: https://www.businesswire.com/news/home/20210601005268/en/
Post by Poweraaaon May 31, 2021 10:50am

Cybin to be included U.S.-listed ETF focused on Psychedelics

$CLXPF included in the first U.S.-listed ETF focused on Psychedelics under ticker $PSY https://prn.to/2Rbz2u2 #psilocybin $CMPS $MNMD
Post by Poweraaaon May 28, 2021 4:32pm

We got Iron Mike, who is a change man because of this...

We got the Champ rooting for this medicine.  https://cnalifestyle.channelnewsasia.com/lifestyle/mike-tyson-says-psychedelics-saved-his-life--now-he-hopes-they-can-change-the-world-14905650 Food ...more  
Post by thorgb1on May 26, 2021 10:05am

News: International patent filed....

News here: https://www.businesswire.com/news/home/20210526005127/en/
Comment by Poweraaaon May 20, 2021 3:11pm

RE:News: Phase II trials approved....

This is good news since, CMPS is only in Phase IIb
Post by thorgb1on May 20, 2021 9:31am

News: New patent filed....

News here: https://www.businesswire.com/news/home/20210520005334/en/
Post by thorgb1on May 18, 2021 9:27am

News: Phase II trials approved....

News here: https://stockhouse.com/news/press-releases/2021/05/18/cybin-granted-irb-approval-for-phase-ii-clinical-trials-of-its-sublingual
Post by hgdcybnon Apr 29, 2021 11:18am

Sharing this post from The Motley Fool on Cybin

Forget Sundial Growers: Put This Stock on Your Radar
Post by Catmando123on Apr 28, 2021 3:37pm

Q1 Earnings Release _ HOLL

Expecting a 2-% pop by Friday - please feel free to do your own DD
Post by hgdcybnon Apr 28, 2021 2:51pm

Great volume on the stock today

Great volume on the stock today. Over 7 million shares traded already.
Post by hgdcybnon Apr 28, 2021 1:10pm

US$10 per share price target from Roth Capital for Cybin

just sharing this US$10 per share price target from Roth Capital on Cybin. This along side MMED Nasdaq listing is great for the industry. https://drive.google.com/file/d/17ehc ...more  
Post by TrojanHorse82on Mar 29, 2021 12:36am

Breakthrough Tech to Measure Real-Time Brain Activity

Cybin (NEO: CYBN) (OTC: CLXPF), a life sciences company advancing psychedelic therapeutics for various psychiatric and neurological conditions, recently announced its collaboration with neurotech ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities